Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2009 Oct;2(10):1175-83.
doi: 10.1016/j.jcmg.2009.06.014.

Relationship between baseline coronary calcium score and demonstration of coronary artery stenoses during follow-up MESA (Multi-Ethnic Study of Atherosclerosis)

Affiliations
Multicenter Study

Relationship between baseline coronary calcium score and demonstration of coronary artery stenoses during follow-up MESA (Multi-Ethnic Study of Atherosclerosis)

Boaz D Rosen et al. JACC Cardiovasc Imaging. 2009 Oct.

Abstract

Objectives: The MESA (Multi-Ethnic Study of Atherosclerosis) is a population-based study of 6,814 men and women. We sought to analyze the relationship between the extent of coronary artery calcium (CAC) at baseline and the severity of coronary stenoses in clinically indicated coronary angiography studies during follow-up.

Background: CAC is an established predictor of major cardiovascular events. Yet, the relationship between CAC and the distribution and severity of coronary artery stenoses has not been widely explored.

Methods: All MESA participants underwent noncontrast enhanced cardiac computed tomography during enrollment to determine baseline CAC. We analyzed 175 consecutive angiography reports from participants who underwent coronary catheterization for clinical indications during a median follow-up period of 18 months. The relationship between baseline CAC and the severity of coronary stenosis detected in coronary angiographies was determined.

Results: Baseline Agatston score was 0 in only 7 of 175 (4%) MESA participants who underwent invasive angiography during follow-up. When coronary arteries were studied separately, 13% to 18% of coronary arteries with >or=75% stenosis had 0 calcium mass scores at baseline. There was close association between baseline calcium mass score and the severity of stenosis in each of the coronary arteries (test for trend, p < 0.001). For example, mean calcium mass scores for <50%, 50% to 74%, and >or=75% stenosis in the left anterior descending coronary artery were 105.1 mg, 157.2 mg, and 302.2 mg, respectively (p < 0.001). Finally, there was a direct relationship between the total Agatston Score at baseline and the number of diseased vessels (test for trend, p < 0.001).

Conclusions: The majority of patients with clinically indicated coronary angiography during follow-up had detectable coronary calcification at baseline. Although there is a significant relationship between the extent of calcification and mean degree of stenosis in individual coronary vessels, 16% of the coronary arteries with significant stenoses had no calcification at baseline.

PubMed Disclaimer

Conflict of interest statement

Reynolds Center. There are no conflicts of interest.

Figures

Figure 1
Figure 1. Relationship between calcium score and the severity of coronary artery stenosis
Calcium mass score as a measure of coronary calcification in each of the coronary arteries with different levels of stenosis. White bars indicate 0–49% stenosis, yellow bars 50–74% and blue bars indicate ≥75% stenosis. (Exception: for the left main artery the corresponding categories are 0–24%, 25–49% and ≥50% stenosis). Standard error bars are shown. Test for trend across the different stenosis categories were significant for each artery (p<0.05 for the LM, p<0.001 in each of the other arteries). Analysis of variance on the log- transformed values of CACP scores was used to test for trend. LM- left main, LAD- left anterior descending, LCX- left circumflex, RCA- right coronary artery.
Figure 2
Figure 2
2A: Distribution of LAD stenosis with increasing LAD CACP mass quartiles 2B: Distribution of LCX stenosis with increasing LCX CACP mass quartiles. 2C: Distribution of RCA stenosis with increasing RCA CACP mass quartiles 2D: Distribution of LM stenosis with increasing LM CACP mass quartiles. The distribution of the severity of coronary stenosis across quartiles of the coronary calcium score in the LAD (2A), LCX (Figure 2B), RCA (2C) and left main coronary artery (2D). In figures 2A-C, the blue portion indicates ≥75% stenosis, yellow indicates 50–74% stenosis and the white part of the bars indicates 0–49% stenosis. In Figure 2D, the blue portion indicates ≥50% stenosis, the yellow portion 25–49% stenosis and the white part of the bars 0–24% stenosis. For all arteries, the Chi square test for association between CACP quartile and % stenosis group was significant (p<0.001 for each). Ranges of CACP scores for each quartile: LAD: I 0 to 0; II. 0.9 to 86.7; III 87.2 to 287.8; IV 290.7 yo 1368.4 LCX: I 0 to 0; II 1.6 to 19.7; III 24.5 to 174.8; IV 176.0 to 1884.8 RCA: I 0 to 0; II 1.2 to 13.6; III 13.6 to 121.3; IV 127.5 to 1799.4 LM: I. 0 to 0; II 0 to 0.78; III 0.78 to 3.7; IV. 4.7 to 543.5.
Figure 2
Figure 2
2A: Distribution of LAD stenosis with increasing LAD CACP mass quartiles 2B: Distribution of LCX stenosis with increasing LCX CACP mass quartiles. 2C: Distribution of RCA stenosis with increasing RCA CACP mass quartiles 2D: Distribution of LM stenosis with increasing LM CACP mass quartiles. The distribution of the severity of coronary stenosis across quartiles of the coronary calcium score in the LAD (2A), LCX (Figure 2B), RCA (2C) and left main coronary artery (2D). In figures 2A-C, the blue portion indicates ≥75% stenosis, yellow indicates 50–74% stenosis and the white part of the bars indicates 0–49% stenosis. In Figure 2D, the blue portion indicates ≥50% stenosis, the yellow portion 25–49% stenosis and the white part of the bars 0–24% stenosis. For all arteries, the Chi square test for association between CACP quartile and % stenosis group was significant (p<0.001 for each). Ranges of CACP scores for each quartile: LAD: I 0 to 0; II. 0.9 to 86.7; III 87.2 to 287.8; IV 290.7 yo 1368.4 LCX: I 0 to 0; II 1.6 to 19.7; III 24.5 to 174.8; IV 176.0 to 1884.8 RCA: I 0 to 0; II 1.2 to 13.6; III 13.6 to 121.3; IV 127.5 to 1799.4 LM: I. 0 to 0; II 0 to 0.78; III 0.78 to 3.7; IV. 4.7 to 543.5.
Figure 2
Figure 2
2A: Distribution of LAD stenosis with increasing LAD CACP mass quartiles 2B: Distribution of LCX stenosis with increasing LCX CACP mass quartiles. 2C: Distribution of RCA stenosis with increasing RCA CACP mass quartiles 2D: Distribution of LM stenosis with increasing LM CACP mass quartiles. The distribution of the severity of coronary stenosis across quartiles of the coronary calcium score in the LAD (2A), LCX (Figure 2B), RCA (2C) and left main coronary artery (2D). In figures 2A-C, the blue portion indicates ≥75% stenosis, yellow indicates 50–74% stenosis and the white part of the bars indicates 0–49% stenosis. In Figure 2D, the blue portion indicates ≥50% stenosis, the yellow portion 25–49% stenosis and the white part of the bars 0–24% stenosis. For all arteries, the Chi square test for association between CACP quartile and % stenosis group was significant (p<0.001 for each). Ranges of CACP scores for each quartile: LAD: I 0 to 0; II. 0.9 to 86.7; III 87.2 to 287.8; IV 290.7 yo 1368.4 LCX: I 0 to 0; II 1.6 to 19.7; III 24.5 to 174.8; IV 176.0 to 1884.8 RCA: I 0 to 0; II 1.2 to 13.6; III 13.6 to 121.3; IV 127.5 to 1799.4 LM: I. 0 to 0; II 0 to 0.78; III 0.78 to 3.7; IV. 4.7 to 543.5.
Figure 2
Figure 2
2A: Distribution of LAD stenosis with increasing LAD CACP mass quartiles 2B: Distribution of LCX stenosis with increasing LCX CACP mass quartiles. 2C: Distribution of RCA stenosis with increasing RCA CACP mass quartiles 2D: Distribution of LM stenosis with increasing LM CACP mass quartiles. The distribution of the severity of coronary stenosis across quartiles of the coronary calcium score in the LAD (2A), LCX (Figure 2B), RCA (2C) and left main coronary artery (2D). In figures 2A-C, the blue portion indicates ≥75% stenosis, yellow indicates 50–74% stenosis and the white part of the bars indicates 0–49% stenosis. In Figure 2D, the blue portion indicates ≥50% stenosis, the yellow portion 25–49% stenosis and the white part of the bars 0–24% stenosis. For all arteries, the Chi square test for association between CACP quartile and % stenosis group was significant (p<0.001 for each). Ranges of CACP scores for each quartile: LAD: I 0 to 0; II. 0.9 to 86.7; III 87.2 to 287.8; IV 290.7 yo 1368.4 LCX: I 0 to 0; II 1.6 to 19.7; III 24.5 to 174.8; IV 176.0 to 1884.8 RCA: I 0 to 0; II 1.2 to 13.6; III 13.6 to 121.3; IV 127.5 to 1799.4 LM: I. 0 to 0; II 0 to 0.78; III 0.78 to 3.7; IV. 4.7 to 543.5.
Figure 3
Figure 3. Relationship between number of diseased coronaries and Agatston score
Agatston calcium score (phantom adjusted) in individuals with non-significant coronary artery disease and in those with one, two, three vessel disease and left main coronary artery disease. Significant vessel disease is defined as ≥ 50% stenosis in the left main artery or ≥ 75 stenosis in the LAD, LCX or RCA coronary arteries. Standard error bars are shown. The test for trend (ANOVA on log transformed CACP) among the four different groups was highly significant (p<0.001).
Figure 4
Figure 4. Distribution of diseased coronaries with increasing Agatston score
The distribution of coronary artery disease among individuals with different Agatston Scores (<100, 100–199, 200–299, 300–399 and ≥400 units). The white portions indicate non-significant CAD, while the gray, blue, yellow and black portions indicate one, two, three vessel disease and left main disease, respectively. The Chi square test for association between calcium score category and extent of disease was highly significant (p<0.001).

Comment in

Similar articles

Cited by

References

    1. Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, Fayad Z, Budoff MJ, Rumberger J, Naqvi TZ, Shaw LJ, Faergeman O, Cohn J, Bahr R, Koenig W, Demirovic J, Arking D, Herrera VL, Badimon J, Goldstein JA, Rudy Y, Airaksinen J, Schwartz RS, Riley WA, Mendes RA, Douglas P, Shah PK. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006;98:2H–15H. - PubMed
    1. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, Lauer MS, Post WS, Raggi P, Redberg RF, Rodgers GP, Shaw LJ, Taylor AJ, Weintraub WS. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2007;49:378–402. - PubMed
    1. Forrester JS. Prevention of plaque rupture: a new paradigm of therapy. Ann Intern Med. 2002;137:823–833. - PubMed
    1. Schmermund A, Erbel R. Unstable coronary plaque and its relation to coronary calcium. Circulation. 2001;104:1682–1687. - PubMed
    1. Mautner GC, Mautner SL, Froehlich J, Feuerstein IM, Proschan MA, Roberts WC, Doppman JL. Coronary artery calcification: assessment with electron beam CT and histomorphometric correlation. Radiology. 1994;192:619–623. - PubMed

Publication types

MeSH terms